rethinkPeptides Search
Menu
Study breakdown

AI Designs Anti-Inflammatory Peptides Targeting the IL-23 Pathway for Autoimmune Disease

ComputationalLow Moderate evidence
The takeaway

A hybrid AI approach combining deep learning with physics simulations designed stable peptides targeting the IL-23 receptor for autoimmune disease.

AI + physics

Hybrid approach combining deep learning peptide generation with molecular dynamics validation

What the researchers found

LSTM-generated peptides with GRU-predicted anti-inflammatory activity showed stable IL-23R binding in molecular dynamics simulations.

Why it matters

Peptide drugs targeting IL-23R could be cheaper and more accessible than antibody therapies for common autoimmune diseases.

The numbers in context

Peptide P4: IC50 = 2 uM; LSTM for generation, GRU for classification, MD for validation; confirmed IL23R specificity.

How the study worked

Hybrid computational pipeline: LSTM peptide generation, GRU anti-inflammatory classification, and molecular dynamics simulations.

Who was studied

N/A

What this study cannot tell us

Computational study — designed peptides need experimental synthesis and biological testing.

How to read the evidence

Computational design study — novel methodology but no experimental validation of biological activity yet.

When this study was published

Published in 2025, representing the cutting edge of AI-driven peptide therapeutics design.

The bigger picture

AI-driven peptide design could democratize drug development by rapidly generating candidates for challenging therapeutic targets.

Questions still open

  • Do the designed peptides actually suppress IL-23-driven inflammation in cells?
  • How do they compare to approved anti-IL-23 antibodies in potency?

Common questions

Can AI design new drugs?
This study used AI to generate peptide candidates and predict their anti-inflammatory properties, then validated them with physics simulations.
What is IL-23 and why target it?
IL-23 is an immune signaling molecule that drives autoimmune diseases like psoriasis and IBD. Blocking it with peptides could offer cheaper alternatives to antibody drugs.

Read the original research

A hybrid protocol for peptide development: integrating deep generative models and physics simulations for biomolecular design targeting IL23R/IL23.

International journal of biological macromolecules, 316(Pt 2), 144652

Citation

Qayyum, Naila; Seo, Hana; Khan, Noman; Manan, Abdul; Ramachandran, Rajath; Haseeb, Muhammad; Kim, Eunha; Choi, Sangdun. (2025). A hybrid protocol for peptide development: integrating deep generative models and physics simulations for biomolecular design targeting IL23R/IL23.. International journal of biological macromolecules, 316(Pt 2), 144652. https://doi.org/10.1016/j.ijbiomac.2025.144652